These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1909749)

  • 1. Anti-anginal therapy and quality of life. A comparison of the effects of transdermal nitroglycerin and long-acting oral nitrates.
    Nissinen A; Wiklund I; Lahti T; Akkila J; Wilson A; Wahl M; Puska P
    J Clin Epidemiol; 1991; 44(9):989-97. PubMed ID: 1909749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
    van de Ven LL; Vermeulen A; Tans JG; Tans AC; Liem KL; Lageweg NC; Lie KI
    Int J Cardiol; 1995 Jan; 47(3):217-23. PubMed ID: 7721498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of placebo, nitroglycerin, and isosorbide dinitrate for effectiveness of relief of angina and duration of action.
    Kattus AA; Alvaro AB; Zohman LR; Coulson AH
    Chest; 1979 Jan; 75(1):17-23. PubMed ID: 105834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged action nitrates in stable angina pectoris].
    Erikssen J; Eidsaunet W; Thaulow E; Røde R; Myhre E
    Tidsskr Nor Laegeforen; 1991 Feb; 111(5):577-82. PubMed ID: 1901181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A summary index for the assessment of quality of life in angina pectoris.
    Wilson A; Wiklund I; Lahti T; Wahl M
    J Clin Epidemiol; 1991; 44(9):981-8. PubMed ID: 1909748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of 2 nitrates. 5-ISMN or nitroglycerin in patients with angina pectoris?].
    Johansson BW
    Lakartidningen; 1989 May; 86(22):2097-9. PubMed ID: 2499741
    [No Abstract]   [Full Text] [Related]  

  • 9. The anti-anginal effect of rapidly acting nitrates in subjects with ergot-induced angina.
    Wendkos MH
    Am J Med Sci; 1967 Jan; 253(1):9-13. PubMed ID: 4959676
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.
    Nicholls DP; Moles K; Gleadhill DN; Booth K; Rowan J; Morton P
    Br J Clin Pharmacol; 1986 Jul; 22(1):15-20. PubMed ID: 3091055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pectoris during uninterrupted exercise.
    Kattus AA; Alvaro AB; Coulson A
    Chest; 1975 Jun; 67(6):640-6. PubMed ID: 805037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
    Karlson BW; Henning R
    Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.
    Rossetti E; Luca C; Bonetti F; Chierchia SL
    J Am Coll Cardiol; 1993 Feb; 21(2):337-42. PubMed ID: 8425995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nitrates in therapy of effort angina in hypotensive patients].
    Idrisova EM; Borovkova NV; Kladieva EA; Chernov VI; Demochko AV; Shishkina AA; Vorob'eva EV; Karpov RS
    Klin Med (Mosk); 2003; 81(11):54-8. PubMed ID: 14689713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
    Kośmicki M; Kowalik I; Jedrzejczyk B; Sadowski Z
    Pol Arch Med Wewn; 2002 Jun; 107(6):509-17. PubMed ID: 12371383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
    Bassan M
    Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.